Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.
Andrea ResoviPerla PersichittiLaura BrunelliLucia MinoliPatrizia BorsottiGiulia GarattiniMatteo TironiErica DugnaniMiriam RedegalliGiulia De SimoneRoberta PastorelliMaria Rosa BaniLorenzo PiemontiDeane F MosherRaffaella GiavazziGiulia TarabolettiDorina BelottiPublished in: Journal of experimental & clinical cancer research : CR (2023)
This study identifies a novel role for pancreatic trypsin and fibronectin cleavage as a mechanism of protection against cancer by the pancreatic microenvironment. The finding of a FAK-FGFR cross-talk in PDAC support the combination of FAK and FGFR inhibitors for PDAC treatment to emulate the protective effect of the normal pancreas against cancer.